24/7 Market News Snapshot 27 June, 2025 – INmune Bio Inc. Common stock (NASDAQ:INMB)

June 27, 2025

DENVER, Colo., 27 June, 2025 (www.247marketnews.com) – (NASDAQ:INMB) are discussed in this article.
INmune Bio Inc. (NASDAQ:INMB) has recently generated notable market activity following its registered direct offering, which marks a significant advancement in its funding initiatives. The Company has secured agreements with two institutional investors to sell 3,000,000 shares of common stock at a price of $6.30 per share, projecting gross proceeds of approximately $19 million. This transaction, following the closing conditions expected around June 30, 2025, will reinforce the Company’s capacity to support working capital and general corporate purposes crucial for ongoing innovation in its clinical programs.

The offering aligns with Nasdaq regulations and will be facilitated by A.G.P./Alliance Global Partners as the exclusive placement agent, underscoring a robust collaboration within the healthcare investment arena. The funds gathered will enable INmune Bio to enhance its pioneering therapies and further its commitment to addressing chronic inflammation and cancer through its unique precision medicine approach, which includes platforms such as the Dominant-Negative Tumor Necrosis Factor (DN-TNF) product and the Natural Killer Cell Priming Platform with INKmune®.

Despite the ongoing excitement, INmune Bio’s stock has faced volatility in recent trading sessions, opening today at $9.30 before showing a significant decline to $7.13, a drop of 13.55%. The market witnessed high trading volumes totaling 41.32 million shares. Technical analysts are watching for support around $6.28 and resistance at $9.30, suggesting that investors should closely monitor critical indicators like RSI or MACD for signs of potential reversal as the Company continues to advance its clinical trials. Overall, INmune Bio remains dedicated to transforming immunotherapy and chronic disease management, although regulatory approval for its treatments cannot be guaranteed at this stage.

Related news for (INMB)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.